Literature DB >> 12560140

Effects of minocycline alone and in combination with mild hypothermia in embolic stroke.

Chen Xu Wang1, Tao Yang, Ashfaq Shuaib.   

Abstract

Inflammatory reactions occurring in the brain after ischemia may contribute to secondary damage. In the present study effects of minocycline, an anti-inflammatory agent, alone or in combination with mild hypothermia, on focal embolic brain ischemia have been examined. Focal ischemic injury was induced by embolizing a preformed clot into the middle cerebral artery (MCA). Infarct volume was measured at 48 h after the injury. Administration of minocycline alone or minocycline plus mild hypothermia reduced infarct volume significantly. However, mild hypothermia in combination with minocycline did not show any additive effect. These results suggest that minocycline is beneficial in focal ischemic brain injury, and the lack of the enhanced neuroprotection may be due to the brief exposure to hypothermia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560140     DOI: 10.1016/s0006-8993(02)04045-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.

Authors:  Sahar Soliman; Tauheed Ishrat; Abdelrahman Y Fouda; Ami Patel; Bindu Pillai; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2015-05-26       Impact factor: 6.829

2.  Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714.

Authors:  Abraham Martín; Raphaël Boisgard; Michael Kassiou; Frédéric Dollé; Bertrand Tavitian
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 3.  Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.

Authors:  David C Hess; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

4.  Minocycline development for acute ischemic stroke.

Authors:  Susan C Fagan; Lydia E Cronic; David C Hess
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

Review 5.  Combination therapy with hypothermia for treatment of cerebral ischemia.

Authors:  Xian N Tang; Liping Liu; Midori A Yenari
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 6.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

7.  Extension of the thrombolytic time window with minocycline in experimental stroke.

Authors:  Yoshihiro Murata; Anna Rosell; Robert H Scannevin; Kenneth J Rhodes; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

8.  Minocycline attenuates brain tissue levels of TNF-α produced by neurons after prolonged hypothermic cardiac arrest in rats.

Authors:  Tomas Drabek; Andreas Janata; Caleb D Wilson; Jason Stezoski; Keri Janesko-Feldman; Samuel A Tisherman; Lesley M Foley; Jonathan D Verrier; Patrick M Kochanek
Journal:  Resuscitation       Date:  2014-02       Impact factor: 5.262

Review 9.  Minocycline for short-term neuroprotection.

Authors:  Hazem F Elewa; Hend Hilali; David C Hess; Livia S Machado; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2006-04       Impact factor: 4.705

10.  Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.

Authors:  Noriyuki Matsukawa; Takao Yasuhara; Koichi Hara; Lin Xu; Mina Maki; Guolong Yu; Yuji Kaneko; Kosei Ojika; David C Hess; Cesar V Borlongan
Journal:  BMC Neurosci       Date:  2009-10-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.